Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Angélique, Desplat"'
Autor:
Jizhe, Hao, Lucie, Brosse, Caroline, Bonnet, Myriam, Ducrocq, Françoise, Padilla, Virginie, Penalba, Angélique, Desplat, Jérôme, Ruel, Patrick, Delmas
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental BiologyREFERENCES. 35(12)
Mepyramine, a first-generation antihistamine targeting the histamine H(1) receptor, was extensively prescribed to patients suffering from allergic reactions and urticaria. Serious adverse effects, especially in case of overdose, were frequently repor
Autor:
Angélique, Desplat, Virginie, Penalba, Emeline, Gros, Thibaud, Parpaite, Bertrand, Coste, Patrick, Delmas
Publikováno v:
The Journal of General Physiology
Desplat et al. show that the Piezo1 channel mediates Ca2+ entry into mouse cholangiocytes as a result of mechanical stress due to cell swelling. Piezo1 thus activates and forms complexes with Pannexin1, which result in force-induced ATP release and s
Autor:
Nathalie Dugot-Senant, Flora Cartier, Sarah Lesjean, Justine Charpentier, Amani Ghousein, Emilie Indersie, Martin Hagedorn, Angélique Desplat, Véronique Trézéguet, Christophe Grosset, Katarzyna B. Hooks, Francis Sagliocco
Publikováno v:
Oncotarget
Oncotarget, 2017, 8 (25), pp.41211-41226. ⟨10.18632/oncotarget.17162⟩
Oncotarget, Impact journals, 2017, 8 (25), pp.41211-41226. ⟨10.18632/oncotarget.17162⟩
Oncotarget, Impact journals, 2017, pp.41211-41226. ⟨10.18632/oncotarget.17162⟩
Oncotarget, 2017, 8 (25), pp.41211-41226. ⟨10.18632/oncotarget.17162⟩
Oncotarget, Impact journals, 2017, 8 (25), pp.41211-41226. ⟨10.18632/oncotarget.17162⟩
Oncotarget, Impact journals, 2017, pp.41211-41226. ⟨10.18632/oncotarget.17162⟩
International audience; Glypican-3 (GPC3) is an oncogene, frequently upregulated in liver malignancies such as hepatocellular carcinoma (HCC) and hepatoblastoma and constitutes a potential molecular target for therapy in liver cancer. Using a functio
Autor:
Jean-William Dupuy, Romano Silvestri, Francis Sagliocco, Melina Petrel, Nadine Thézé, Sandrine Fédou, Angélique Desplat, Anne-Aurélie Raymond, Véronique Guyonnet-Duperat, Katarzyna B. Hooks, Pierre Thiébaud, Caroline Capdevielle, Martin Hagedorn, Justine Charpentier, Christophe Grosset
Publikováno v:
Neuro-Oncology
Neuro-Oncology, 2019, pp.noz215. ⟨10.1093/neuonc/noz215⟩
Neuro Oncol
Neuro-Oncology, Oxford University Press (OUP), 2019, pp.noz215. ⟨10.1093/neuonc/noz215⟩
Neuro-Oncology, 2019, pp.noz215. ⟨10.1093/neuonc/noz215⟩
Neuro Oncol
Neuro-Oncology, Oxford University Press (OUP), 2019, pp.noz215. ⟨10.1093/neuonc/noz215⟩
Background Diffuse midline glioma (DMG) is a pediatric malignancy with poor prognosis. Most children die less than one year after diagnosis. Recently, mutations in histone H3 have been identified and are believed to be oncogenic drivers. Targeting th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf08a12bbf779d839d2728191d5736ad
https://www.hal.inserm.fr/inserm-02437920
https://www.hal.inserm.fr/inserm-02437920